EGR1-mediated linc01503 promotes cell cycle progression and tumorigenesis in gastric cancer.
Zhonghua MaXiangyu GaoYou ShuaiXiaolong WuYan YanXiaofang XingJia Fu JiPublished in: Cell proliferation (2020)
EGR1-activated linc01503 could epigenetically silence DUSP5/CDKN1A expression to mediate cell cycle progression and tumorigenesis, implicating it as a prospective target for GC therapeutics.